Candel Therapeutics shares owned by EntryPoint Capital
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by EntryPoint Capital
from 13F filings
Historical chart of EntryPoint Capital investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by EntryPoint Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $95k | 19k | 5.10 |
| 2025-06-30 | $87k | 17k | 5.06 |
| 2025-03-31 | $101k | 18k | 5.65 |